Clinical Trial Update: Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating salvage therapy with high/low methotrexate for loss of response to infliximab dose escalation in Crohn's disease (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)
• methotrexate (high/low dose) (methotrexate)

Snippet

Sponsor: Prof. Arie Levine | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED